Search Results - "Testa, JE"

  • Showing 1 - 15 results of 15
Refine Results
  1. 1

    Subtractive proteomic mapping of the endothelial surface in lung and solid tumours for tissue-specific therapy by Schnitzer, Jan E, Oh, Phil, Li, Yan, Yu, Jingyi, Durr, Eberhard, Krasinska, Karolina M, Carver, Lucy A, Testa, Jacqueline E

    Published in Nature (10-06-2004)
    “…The molecular complexity of tissues and the inaccessibility of most cells within a tissue limit the discovery of key targets for tissue-specific delivery of…”
    Get full text
    Journal Article
  2. 2

    Direct proteomic mapping of the lung microvascular endothelial cell surface in vivo and in cell culture by Schnitzer, Jan E, Durr, Eberhard, Yu, Jingyi, Krasinska, Karolina M, Carver, Lucy A, Yates, John R, Testa, Jacqueline E, Oh, Phil

    Published in Nature biotechnology (01-08-2004)
    “…Endothelial cells can function differently in vitro and in vivo; however, the degree of microenvironmental modulation in vivo remains unknown at the molecular…”
    Get full text
    Journal Article
  3. 3

    Screening Phage Display Libraries for Organ-Specific Vascular Immunotargeting in vivo by Valadon, Philippe, Garnett, Jeff D., Testa, Jacqueline E., Bauerle, Marc, Oh, Phil, Schnitzer, Jan E.

    “…The molecular diversity of the luminal endothelial cell surface arising in vivo from local variations in genetic expression and tissue microenvironment may…”
    Get full text
    Journal Article
  4. 4

    Subtractive immunization using highly metastatic human tumor cells identifies SIMA135 CDCP1, a 135 kDa cell surface phosphorylated glycoprotein antigen by HOOPER, John D, ZIJLSTRA, Andries, AIMES, Ronald T, HONGYAN LIANG, CLAASSEN, Gisela F, TARIN, David, TESTA, Jacqueline E, QUIGLEY, James P

    Published in Oncogene (27-03-2003)
    “…We have previously used a subtractive immunization (SI) approach to generate monoclonal antibodies (mAbs) against proteins preferentially expressed by the…”
    Get full text
    Journal Article
  5. 5

    Eukaryotic expression cloning with an antimetastatic monoclonal antibody identifies a tetraspanin (PETA-3/CD151) as an effector of human tumor cell migration and metastasis by TESTA, J. E, BROOKS, P. C, LIN, J.-M, QUIGLEY, J. P

    Published in Cancer research (Chicago, Ill.) (01-08-1999)
    “…A monoclonal antibody (mAb), 50-6, generated by subtractive immunization, was found to specifically inhibit in vivo metastasis of a human epidermoid carcinoma…”
    Get full text
    Journal Article
  6. 6

    Targeting the proteome/epitome, implementation of subtractive immunization by Zijlstra, Andries, Testa, Jacqueline E, Quigley, James P

    “…Monoclonal antibody technology has generated invaluable tools for both the analytical and clinical sciences. However, standard immunization approaches…”
    Get full text
    Journal Article
  7. 7

    Borrelia burgdorferi binds plasminogen, resulting in enhanced penetration of endothelial monolayers by COLEMAN, J. L, SELLATI, T. J, TESTA, J. E, KEW, R. R, FURIE, M. B, BENACH, J. L

    Published in Infection and Immunity (01-07-1995)
    “…Services IAI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon…”
    Get full text
    Journal Article
  8. 8

    The role of urokinase-type plasminogen activator in aggressive tumor cell behavior by TESTA, J. E, QUIGLEY, J. P

    Published in Cancer and metastasis reviews (01-12-1990)
    “…The correlation between urokinase-type plasminogen activator (uPA) expression and tumor cell invasion and metastasis has been well documented. Urokinase…”
    Get full text
    Journal Article
  9. 9

    Loss of the metastatic phenotype by a human epidermoid carcinoma cell line, HEp-3, is accompanied by increased expression of tissue inhibitor of metalloproteinase 2 by TESTA, J. E

    Published in Cancer research (Chicago, Ill.) (15-10-1992)
    “…The human epidermoid carcinoma cell line HEp-3 gives rise to spontaneous metastases in nude mice and in the chick chorioallantoic membrane (CAM) assay system…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Co-inoculation of human and murine carcinoma cells induces reciprocal suppression of metastasis by both cell lines by Nielsen-Preiss, S M, Quigley, J P, Testa, J E

    Published in Clinical & experimental metastasis (01-01-1999)
    “…The interactions of two cell lines having different metastatic properties, and the subsequent effects on dissemination were investigated using the chicken…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14

    Urokinase-type plasminogen activator biosynthesis is induced by the EJ-Ha-ras oncogene in CL26 mouse colon carcinoma cells by Testa, J E, Medcalf, R L, Cajot, J F, Schleuning, W D, Sordat, B

    Published in International journal of cancer (15-05-1989)
    “…CL26 murine colon carcinoma cells express urokinase-type plasminogen activator (u-PA) mRNA and activity after transfection with the activated c-Ha-ras-I…”
    Get more information
    Journal Article
  15. 15

    Molecular mechanisms involved in T cell activation. III. The role of extracellular calcium in antigen-induced lymphokine production and interleukin 2-induced proliferation of cloned cytotoxic T lymphocytes by Harris, DT, Kozumbo, WJ, Testa, JE, Cerutti, PA, Cerottini, JC

    Published in The Journal of immunology (1950) (01-02-1988)
    “…The role that extracellular calcium plays in activating resting cloned cytotoxic T lymphocytes (CTL) to proliferate and to produce lymphokines was examined. In…”
    Get full text
    Journal Article